News

Featured Articles

Cristalia products with Nemera’s reusable pen injector commercialized in Brazil.

Cristalia’s human growth hormone will be administered with CRISPEN®. Approved by ANVISA1, CRISPEN® is part of Nemera’s state-of-the-art pen injector platform PENDURA AD.

All Categories
2020
2021
2023
2024
Corporate
COVID
ESG
Events
Plants
Products

Products

A new ENT device: UniSpray

27/10/2021

We are happy to announce the launch of Unispray, our unidose system primarily for systemic-acting drug administration.

2021 Products

Symbioze won the Pharmapack Award 2021

30/09/2021

On October 12th, during the Pharmapack Awards Ceremony, a team of industry experts awarded Symbioze, Nemera’s large-volume on-body injector, with the Pharmapack Award in the “Connected Devices and Wearables” category.